Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $7.81 +0.40 (+5.40%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.73Holdings in PILL have an aggregate rating of Moderate Buy based on 363 analyst ratings issued in the past year covering 44 companies (81.9% of the portfolio).PILL Aggregate Price Target$7.81High Prediction$7.81Average Prediction$7.81Low Prediction$7.81Holdings in PILL have an aggregate price target of $7.81 and a range of $7.81 to $7.81 covering 44 companies (81.9% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy21 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.23%PFEPfizer$26.63+1.2%4.9944 of 5 stars2.50$32.00 20.2%16Positive News3.21%TARSTarsus Pharmaceuticals$46.74+0.5%1.6431 of 5 stars3.00$54.20 16.0%63.15%RPRXRoyalty Pharma$30.30-1.5%4.8342 of 5 stars3.00$41.67 37.5%7Positive News3.09%OGNOrganon & Co.$15.89+0.9%4.8778 of 5 stars2.40$21.33 34.3%5Positive News3.04%MRKMerck & Co., Inc.$96.18-1.8%4.9993 of 5 stars2.67$123.00 27.9%21Analyst ForecastNews CoveragePositive News3.04%BMYBristol-Myers Squibb$57.01+1.3%4.9169 of 5 stars2.29$56.27 -1.3%21Positive News3.02%JAZZJazz Pharmaceuticals$121.43+0.2%4.9845 of 5 stars2.87$177.00 45.8%15Short Interest ↓News CoveragePositive News3.00%LLYEli Lilly and Company$741.98+2.2%4.9972 of 5 stars2.81$1,002.22 35.1%212.98%ITCIIntra-Cellular Therapies$126.50+0.2%3.8327 of 5 stars2.67$100.31 -20.7%152.94%JNJJohnson & Johnson$148.10+0.7%4.9894 of 5 stars2.43$173.27 17.0%14Upcoming EarningsAnalyst ForecastOptions VolumeNews CoveragePositive News2.84%VTRSViatris$11.33+0.3%2.038 of 5 stars2.00$13.67 20.6%32.82%ZTSZoetis$167.50+1.0%4.8736 of 5 stars3.09$211.89 26.5%11News CoveragePositive News2.80%ELANElanco Animal Health$12.04+0.1%4.4024 of 5 stars2.25$16.43 36.5%82.78%PRGOPerrigo$24.44+2.5%4.9592 of 5 stars2.40$35.00 43.2%52.61%CORTCorcept Therapeutics$61.11+10.5%4.115 of 5 stars3.00$65.25 6.8%52.59%EWTXEdgewise Therapeutics$27.39+4.3%2.1524 of 5 stars3.00$43.17 57.6%6Short Interest ↑2.56%AXSMAxsome Therapeutics$96.18+4.6%4.6409 of 5 stars3.00$130.69 35.9%13Analyst ForecastAnalyst RevisionNews Coverage2.49%HROWHarrow$36.10+6.6%2.4738 of 5 stars3.00$63.00 74.5%3Positive News2.39%HRMYHarmony Biosciences$40.46+3.6%4.6026 of 5 stars3.00$55.00 35.9%8Analyst RevisionNews CoverageGap Up2.03%PBHPrestige Consumer Healthcare$79.36+1.0%3.2686 of 5 stars2.50$85.25 7.4%41.97%COLLCollegium Pharmaceutical$33.19-0.5%4.2516 of 5 stars2.80$43.80 32.0%51.68%ANIPANI Pharmaceuticals$58.35-0.2%4.5973 of 5 stars3.00$77.71 33.2%8Short Interest ↓1.63%AMPHAmphastar Pharmaceuticals$36.03+0.9%4.5164 of 5 stars2.50$60.33 67.5%4Short Interest ↑1.61%ARVNArvinas$18.57+2.9%2.6157 of 5 stars2.93$63.50 241.9%151.37%CRMDCorMedix$12.49+2.6%2.4423 of 5 stars3.00$15.67 25.4%61.36%SUPNSupernus Pharmaceuticals$38.58+2.2%3.7493 of 5 stars2.67$46.50 20.5%3Positive News1.33%WVEWave Life Sciences$11.10+1.0%4.4314 of 5 stars3.00$22.22 100.2%91.28%PCRXPacira BioSciences$22.84+2.1%2.6482 of 5 stars2.20$24.50 7.3%10News Coverage1.26%LQDALiquidia$13.62+5.7%2.9337 of 5 stars3.11$25.38 86.3%91.19%LGNDLigand Pharmaceuticals$117.36+4.9%4.9484 of 5 stars3.00$147.00 25.3%61.15%OCULOcular Therapeutix$8.09+1.0%3.5671 of 5 stars2.86$16.71 106.6%71.08%AMRXAmneal Pharmaceuticals$8.56+3.6%3.5241 of 5 stars2.80$10.00 16.8%5Short Interest ↓1.04%INVAInnoviva$18.75+0.9%0.9312 of 5 stars3.0010.91%EOLSEvolus$13.48+28.3%4.1036 of 5 stars3.00$23.00 70.6%4Analyst ForecastNews CoverageGap UpHigh Trading Volume0.85%EYPTEyePoint Pharmaceuticals$7.63+2.0%1.8063 of 5 stars3.00$26.63 249.0%10Short Interest ↑0.74%ELVNEnliven Therapeutics$22.00+2.5%2.0463 of 5 stars3.20$38.25 73.9%50.71%ZVRAZevra Therapeutics$8.15+1.2%2.0434 of 5 stars3.13$21.57 164.7%80.69%ESPREsperion Therapeutics$2.15-2.7%3.8427 of 5 stars2.40$7.30 239.5%50.66%PHATPhathom Pharmaceuticals$6.79-2.4%2.442 of 5 stars2.75$23.00 238.7%4High Trading Volume0.63%NUVBNuvation Bio$2.60+3.4%2.2478 of 5 stars3.00$7.40 185.2%5Gap Down0.57%MNMDMind Medicine (MindMed)$7.18+0.3%2.1302 of 5 stars3.25$26.75 272.6%120.56%PLRXPliant Therapeutics$11.07-1.2%3.7804 of 5 stars3.13$40.50 265.9%80.51%XERSXeris Biopharma$3.34+4.4%3.3915 of 5 stars2.67$4.87 45.7%3News CoverageGap Up0.47%PAHCPhibro Animal Health$21.51+3.3%4.2547 of 5 stars1.50$20.50 -4.7%4 This page (NYSEARCA:PILL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
